skip to main content
Close Icon We use cookies to improve your website experience.  To learn about our use of cookies and how you can manage your cookie settings, please see our Cookie Policy.  By continuing to use the website, you consent to our use of cookies.
Global Search Configuration

New product launches and label expansions will drive growth despite genericization of key brands


What’s the overall outlook for the multiple myeloma (MM) market? Positive or negative?


The answer is positive! Datamonitor Healthcare predicts that the extended indications for key MM drugs will lead to considerable uptake across the treatment algorithm, which will strongly contribute to the total sales of the overall MM market.

 

Highlights from this report include:

  • 20 year forecasts of the incidence and prevalence of MM

  • Overview of the current competitive landscape in MM

  • Patient-based forecast of the MM market over 2015–24
Multiple-Myeloma-Desease-Coverage

Read also

;

Next steps

Getting a demo tailored to your needs is the best way to see how our solutions will help you gain an advantage.

Request live demo now:

Our team is always happy to hear from you. Please call us at:

  • US Toll-Free  : +1 888 670 8900
  • US Toll           : +1 908 547 2200
  • UK & Europe : +44 (20) 337 73737
  • Australia        : +61 2 8705 6907
  • Japan              : +81 3 6273 4260

Or please submit your inquiry via the form so that we can provide you the best possible customer service.

Have an immediate and specific information need?

Browse and buy from 1000s of analysis and research reports now: